These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1034 related articles for article (PubMed ID: 30119241)

  • 41. MicroRNA-1290 promotes esophageal squamous cell carcinoma cell proliferation and metastasis.
    Li M; He XY; Zhang ZM; Li S; Ren LH; Cao RS; Feng YD; Ji YL; Zhao Y; Shi RH
    World J Gastroenterol; 2015 Mar; 21(11):3245-55. PubMed ID: 25805931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-429 inhibits the proliferation and migration of esophageal squamous cell carcinoma cells by targeting RAB23 through the NF-κB pathway.
    Wang Y; Yu XJ; Zhou W; Chu YX
    Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1202-1210. PubMed ID: 32096149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upregulation of miR-1269 Contributes to the Progression of Esophageal Squamous Cell Cancer Cells and Is Associated With Poor Prognosis.
    Bai X; Wang Q; Rui X; Li X; Wang X
    Technol Cancer Res Treat; 2021; 20():1533033820985858. PubMed ID: 33416035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
    Yang H; Wei YN; Zhou J; Hao TT; Liu XL
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh's esophageal squamous cell carcinoma.
    Dai F; Liu T; Zheng S; Liu Q; Yang C; Zhou J; Chen Y; Sheyhidin I; Lu X
    Tumour Biol; 2016 Nov; 37(11):14595-14604. PubMed ID: 27619676
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-622 functions as a tumor suppressor and directly targets E2F1 in human esophageal squamous cell carcinoma.
    Song C; Lu P; Shi W; Sun G; Wang G; Huang X; Wang Z; Wang Z
    Biomed Pharmacother; 2016 Oct; 83():843-849. PubMed ID: 27501502
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of miR-429 on cell migration and invasion by targeting Slug in esophageal squamous cell carcinoma.
    Zong M; Liu Y; Zhang K; J Y; Chen L
    Pathol Res Pract; 2019 Sep; 215(9):152526. PubMed ID: 31324391
    [TBL] [Abstract][Full Text] [Related]  

  • 48. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS.
    Zhu L; Wang Z; Fan Q; Wang R; Sun Y
    Oncol Rep; 2014 Jan; 31(1):280-6. PubMed ID: 24154848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA-182 promoted esophageal squamous cell carcinoma cell growth and metastasis via targeting YWHAG.
    Bai Q; Yu J; Li Y; Ma J; Gou Y
    J BUON; 2018; 23(5):1439-1447. PubMed ID: 30570871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression.
    He Z; Li W; Zheng T; Liu D; Zhao S
    J Exp Clin Cancer Res; 2020 Jul; 39(1):140. PubMed ID: 32698859
    [TBL] [Abstract][Full Text] [Related]  

  • 51. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
    BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNA XIST promotes the progression of esophageal squamous cell carcinoma through sponging miR-129-5p and upregulating CCND1 expression.
    Wang H; Li H; Yu Y; Jiang Q; Zhang R; Sun H; Xing W; Li Y
    Cell Cycle; 2021 Jan; 20(1):39-53. PubMed ID: 33345719
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-490-3p inhibited the proliferation and metastasis of esophageal squamous cell carcinoma by targeting HMGA2.
    Kang NN; Ge SL; Zhang RQ; Huang YL; Liu SD; Wu KM
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8298-8305. PubMed ID: 30556870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MicroRNA-1 suppresses proliferation, migration and invasion by targeting Notch2 in esophageal squamous cell carcinoma.
    Liu W; Li M; Chen X; Zhu S; Shi H; Zhang D; Cheng C; Li B
    Sci Rep; 2018 Mar; 8(1):5183. PubMed ID: 29581534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-214 inhibits the proliferation and invasion of esophageal squamous cell carcinoma cells by targeting CDC25B.
    Wang M; Wang L; Zhang M; Li X; Zhu Z; Wang H
    Biomed Pharmacother; 2017 Nov; 95():1678-1683. PubMed ID: 28954387
    [TBL] [Abstract][Full Text] [Related]  

  • 56. miR-550a-3/NFIC plays a driving role in esophageal squamous cell cancer cells proliferation and metastasis partly through EMT process.
    Wang H; Shi X; Wu S
    Mol Cell Biochem; 2020 Sep; 472(1-2):115-123. PubMed ID: 32567032
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1.
    Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H
    Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8.
    Li M; Tian L; Ren H; Chen X; Wang Y; Ge J; Wu S; Sun Y; Liu M; Xiao H
    J Transl Med; 2015 Aug; 13():271. PubMed ID: 26286725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA‑675‑3p promotes esophageal squamous cell cancer cell migration and invasion.
    Xiao Q; Chen T; Wu Y; Wu W; Xu Y; Gong Z; Chen S
    Mol Med Rep; 2018 Oct; 18(4):3631-3640. PubMed ID: 30106155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. hsa_circ_0006168 sponges miR-100 and regulates mTOR to promote the proliferation, migration and invasion of esophageal squamous cell carcinoma.
    Shi Y; Guo Z; Fang N; Jiang W; Fan Y; He Y; Ma Z; Chen Y
    Biomed Pharmacother; 2019 Sep; 117():109151. PubMed ID: 31229921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.